Get in touch
555-555-5555
mymail@mailservice.com
Santorini Scientific sponsor Heart-On-a-Chip PhD
1 January 2022
Examining cardiac allograft vasculopathy
Santorini Scientific and UWE are co-funding a PhD on ‘biomarkers of cardiac rejection’.
The PhD was launched in January 2022 and Esther Atkinson has since focused specifically on biomarkers of cardiac allograft vasculopathy (CAV), a condition which causes narrowing of the arteries and affects more than one third of heart transplant patients.
Remodelling of the infarcted heart: piezoelectric multifunctional patch video release
Santorini Scientific Ltd and UWE Bristol announce new Accelerated Knowledge Transfer (AKT): Accelerating development of a multi-sensor, multi-culture cell model for evaluation of heart transplant rejection to enable personalised treatment
After a competitive process, project funding has been awarded by Innovate UK to Santorini Scientific for modelling rejection as a platform for future post-transplant therapies
Developing a model for analysing heart transplant patient data
SSL secured AHSN Network Grant in Collaboration with the University of The West of England
Santorini Scientific is participating in a European scientific study funded by Horizon Europe to help the 2 million people in Europe affected by heart disease every year
Non-invasive Diagnostics will reduce patients’ stress factors and infection risks
SSL is looking to purchase a 3D Bioprinter and technical support. Can you help? If so, please download and reply to our tender.
27 June 2022: ERDF funding under the KEEP+ programme to work with UWE
25 May 2022: Exploring TReg therapy to reduce post-transplant rejection